Komori
Techno Medica (6678) · PolicyAdvanced

Sound Financing Based on Operating Cash Flow

First written in FY2016. 9 of 23 entries say "Worsened", first in FY2019-Q2. Latest entry: FY2026.

23entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018WorsenedFY2023-Q2 – FY2024-Q22016: 22017: 220172018: 220182019: 220192020: 220202021: 220212022: 220222023: 220232024: 220242025: 220252026: 32026
Same theme, other companies
Funding Capital Expenditures and Working Capital Primarily Through Operating Cash FlowA theme 66 companies write about · 0 as a headwind · 62 as a tailwind

10 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 66 companies compared. The sentences above are computed from all 66.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Cash provided by operating activities for the fiscal year amounted to ¥1,100,442 thousand, an increase of ¥122,907 thousand year on year.」

    Operating cash flow remained positive and increased by ¥123 million from the previous fiscal year to ¥1,100 million. Fund generation recovered against the policy of using operating activities as the funding base for sustaining growth.
  2. FY2026-H1WorsenedAnnual report

    「During the interim accounting period, funds generated from operating activities totaled ¥270 million, a decrease of ¥1,157 million year on year.」

    Operating cash flow remained positive but decreased by ¥1,157 million year on year to ¥270 million. Fund generation declined against the policy of using operating activities as the funding base.
  3. FY2025WorsenedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥978 million, a decrease of ¥165 million from the previous fiscal year.」

    Operating cash flow remained positive but decreased by ¥165 million from the previous fiscal year. Fund generation declined against the policy of using funds generated from operating activities as the basis for sustaining growth.
  4. FY2025-H1AdvancedAnnual report

    「During the interim accounting period, funds generated from operating activities totaled ¥1,427 million, an increase of ¥953 million year on year.」

    Operating cash flow remained positive at ¥1,427 million and increased by ¥953 million year on year. Fund generation recovered against the policy of using operating cash flow as the funding base needed to sustain growth.
  5. FY2024AdvancedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥1,143 million, an increase of ¥255 million from the previous fiscal year.」

    Operating cash flow remained positive at ¥1,143 million and increased by ¥255 million from the previous fiscal year. Fund generation recovered against the policy of using funds generated from operating activities as the funding base needed to sustain growth.
  6. FY2024-Q2WorsenedAnnual report

    「During the cumulative second quarter, funds generated from operating activities totaled ¥474 million, a decrease of ¥441 million year on year.」

    Operating cash flow remained positive but decreased by ¥441 million year on year to ¥474 million. Fund generation declined against the policy of using funds generated from operating activities as the basis for sustaining growth.
  7. FY2023WorsenedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥887 million, a decrease of ¥1,176 million from the previous fiscal year.」

    Operating cash flow remained positive but decreased by ¥1,176 million from the previous fiscal year. Fund generation declined against the policy of using operating cash flow as the funding base.
  8. FY2023-Q2WorsenedAnnual report

    「During the cumulative second quarter, funds generated from operating activities totaled ¥915 million, a decrease of ¥507 million year on year.」

    Operating cash flow remained positive but decreased by ¥507 million year on year. Fund generation declined against the policy of using funds generated from operating activities as the basis for sustaining growth.
  9. FY2022AdvancedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥2,063 million, an increase of ¥1,238 million from the previous fiscal year.」

    Operating cash flow remained positive and increased by ¥1,238 million from the previous fiscal year. Fund generation improved against the policy of using funds generated from operating activities as the basis for sustaining growth.
  10. FY2022-Q2AdvancedAnnual report

    「During the cumulative second quarter, funds generated from operating activities totaled ¥1,422 million, an increase of ¥663 million year on year.」

    Operating cash flow remained positive at ¥1,422 million and increased by ¥663 million year on year. Fund generation recovered against the policy of using operating cash flow as the funding base needed to sustain growth.
  11. FY2021WorsenedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥825 million, a decrease of ¥444 million from the previous fiscal year.」

    Operating cash flow remained positive but decreased by ¥444 million from the previous fiscal year. Fund generation declined against the policy of using funds generated from operating activities as the basis for sustaining growth.
  12. FY2021-Q2WorsenedAnnual report

    「During the cumulative second quarter, funds generated from operating activities totaled ¥759 million, a decrease of ¥119 million year on year.」

    Operating cash flow remained positive but decreased by ¥119 million year on year. Fund generation declined against the policy of using operating cash flow as the funding base needed to sustain growth.
  13. FY2020AdvancedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥1,269 million, an increase of ¥565 million from the previous fiscal year.」

    Operating cash flow remained positive at ¥1,269 million and increased by ¥565 million from the previous fiscal year. Fund generation recovered against the policy of using operating cash flow as the funding base.
  14. FY2020-Q2AdvancedAnnual report

    「During the cumulative second quarter, funds generated from operating activities totaled ¥878 million, an increase of ¥372 million year on year.」

    Operating cash flow remained positive at ¥878 million and increased by ¥372 million year on year. Fund generation recovered against the policy of using operating cash flow as the funding base needed to sustain growth.
  15. FY2019WorsenedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥704 million, a decrease of ¥813 million from the previous fiscal year.」

    Operating cash flow remained positive but decreased by ¥813 million from the previous fiscal year. Fund generation declined against the policy of using funds generated from operating activities as the basis for sustaining growth.
  16. FY2019-Q2WorsenedAnnual report

    「During the cumulative second quarter, funds generated from operating activities totaled ¥505 million, a decrease of ¥500 million year on year.」

    Operating cash flow remained positive at ¥505 million but decreased by ¥500 million year on year. Fund generation declined during the cumulative quarter against the policy of using operating cash flow as the funding base needed to sustain growth.
  17. FY2018RestatedAnnual report

    「During the fiscal year, funds generated from operating activities totaled ¥1,517 million, an increase of ¥822 million from the previous fiscal year.」

    The company generated funds from operating activities in line with its policy of using operating cash flow as its funding base.
  18. FY2018-Q2RestatedAnnual report

    「During the cumulative second quarter, funds generated from operating activities totaled ¥1,005 million, an increase of ¥876 million year on year.」

    The company generated funds from operating activities in line with its policy of using operating cash flow as the funding base needed to sustain growth.
  19. FY2017RestatedAnnual report

    「Depending on the use and purpose of the funds, we are working to secure financing by combining methods such as cash flow generated from operating activities and borrowings from financial institutions.」

    The company continues to pursue a financial policy of securing the necessary funds by combining operating cash flow and borrowings.
  20. FY2017-Q2RestatedAnnual report

    「We will continue working to maintain financial soundness and generate cash flow from operating activities so that we can secure the working capital and funds for capital investment necessary to sustain growth.」

    The company continues to pursue a financial policy that uses cash flow from operating activities as the funding base needed to sustain growth.
  21. FY2016First statedAnnual report

    「We will continue working to maintain financial soundness and generate cash flow from operating activities so that we can secure the working capital and funds for capital investment necessary to sustain growth.」

    The company indicates a policy of maintaining financial soundness and using cash flow from operating activities as the basis for working capital and capital investment funds.
Moved together

"Expanding Market Share of Blood Collection Tube Preparation Equipment" moved the same way as this thread, in the same document, in 14 of its 23 moves.

141312987★123456
  1. ★This thread
  2. 1Expanding Market Share of Blood Collection Tube Preparation Equipment14×
  3. 2Expansion of Recurring Sales through Related Consumables and Maintenance Services13×
  4. 3Currency, Distributor, and Maintenance and Servicing Risks Associated with Overseas Exports12×
  5. 4Achieving Stable Growth in Net Sales and a 20% Ordinary Profit Margin on Net Sales9×
  6. 5Equipment sales weighted toward the second half and fourth quarter8×
  7. 6Uncertainty in the Global Economy Surrounding the Slowdown in Emerging-Market Economies and the UK's Withdrawal from the EU7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Techno Medica yet. It last moved in the Earnings presentation of 2026-05-26: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.